Fernwood Investment Management, LLC Jounce Therapeutics, Inc. Transaction History

Fernwood Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$6.01 - $8.54 $34,118 - $48,481	5,677 Added 21.36%	32,259 $219,000
Q4 2021 Feb 09, 2022	SELL	$7.11 - $9.64 $725 - $983	-102 Reduced 0.38%	26,582 $222,000
Q3 2021 Oct 28, 2021	BUY	$5.04 - $8.73 $37,613 - $65,151	7,463 Added 38.83%	26,684 $198,000
Q2 2021 Aug 05, 2021	BUY	$6.58 - $10.66 $41,960 - $67,978	6,377 Added 49.65%	19,221 $131,000
Q1 2021 May 06, 2021	BUY	$6.73 - $13.87 $86,440 - $178,146	12,844 New	12,844 $132,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.